- Home
- MEDP vs QGEN Comparison
MEDP vs QGEN Comparison
Compare MEDP & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- QGEN
- Stock Information
- Founded
- MEDP 1992
- QGEN 1986
- Country
- MEDP United States
- QGEN Netherlands
- Employees
- MEDP N/A
- QGEN N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MEDP Health Care
- QGEN Health Care
- Exchange
- MEDP Nasdaq
- QGEN Nasdaq
- Market Cap
- MEDP 10.5B
- QGEN 9.9B
- IPO Year
- MEDP 2016
- QGEN 1996
- Fundamental
- Price
- MEDP $312.74
- QGEN $39.85
- Analyst Decision
- MEDP Buy
- QGEN Buy
- Analyst Count
- MEDP 10
- QGEN 8
- Target Price
- MEDP $373.22
- QGEN $49.79
- AVG Volume (30 Days)
- MEDP 384.3K
- QGEN 1.1M
- Earning Date
- MEDP 04-21-2025
- QGEN 04-28-2025
- Dividend Yield
- MEDP N/A
- QGEN 3.31%
- EPS Growth
- MEDP 42.23
- QGEN N/A
- EPS
- MEDP 12.63
- QGEN 0.37
- Revenue
- MEDP $2,109,054,000.00
- QGEN $1,978,214,000.00
- Revenue This Year
- MEDP $4.64
- QGEN $5.15
- Revenue Next Year
- MEDP $9.74
- QGEN $6.49
- P/E Ratio
- MEDP $24.73
- QGEN $107.70
- Revenue Growth
- MEDP 11.84
- QGEN 0.66
- 52 Week Low
- MEDP $302.01
- QGEN $37.63
- 52 Week High
- MEDP $459.77
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- MEDP 40.74
- QGEN 49.85
- Support Level
- MEDP $314.00
- QGEN $39.35
- Resistance Level
- MEDP $331.24
- QGEN $40.11
- Average True Range (ATR)
- MEDP 8.84
- QGEN 0.54
- MACD
- MEDP -0.39
- QGEN 0.18
- Stochastic Oscillator
- MEDP 18.32
- QGEN 80.88
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).